(NEW YORK)Medarex Inc. and the Massachusetts Biologics Laboratories said Monday that their two drug candidates reduced diarrhea in a clinical trial compared with a placebo.READ MORE
Among the premarket activity stories for Thursday, Sept. 11, from AP Financial News: WASHINGTON (AP)--Government data is expected to show that the number of newly laid-off people f...READ MORE
(NEW YORK)A JPMorgan analyst downgraded shares of Medarex Inc. Thursday, saying the stock will trade in place until the second half of 2009, when Medarex reports critical late-stage trial da...READ MORE
(PRINCETON, N.J.)Medarex Inc. said Monday it received a milestone payment after Pfizer Inc. planned to begin clinical trials of a product Pfizer developed using Madera's ultimo technology.READ MORE
(PRINCETON, N.J.)Biotechnology company Medarex Inc. said late Tuesday its second-quarter loss widened on a mix of lower revenue and a charge related to its affiliate Avant Immunotherapeutics.READ MORE
(NEW YORK)Shares of biotechnology company Medarex Inc. fell Monday after analysts expressed concerns over the company's late-stage melanoma drug candidate ipilimumab.READ MORE
Among the stock activity stories for Monday, June 2, from AP Financial News: NEW YORK (AP)--Shares of biotechnology company Medarex Inc. fell Monday after analysts expressed concer...READ MORE